Literature DB >> 33963521

Physical Exercise Training Improves Judgment and Problem-Solving and Modulates Serum Biomarkers in Patients with Alzheimer's Disease.

Joni Marcio de Farias1, Natalia Dos Santos Tramontin2, Eduarda Valim Pereira1, Geiziane Laurindo de Moraes1, Beatriz Giusti Furtado1, Lariani Tamires Witt Tietbohl3, Bárbara Da Costa Pereira3, Kellen Ugioni Simon3, Alexandre Pastoris Muller4,5,6.   

Abstract

Alzheimer's disease (AD) is characterized by progressive impairment of memory, with an etiology involving oxidative stress and inflammation. Exercise training is a safe, efficacious, and economic approach to manage neurodegenerative diseases. In AD, the biomarkers of oxidative damage to lipids, proteins, and DNA are elevated. In the present study, we aimed to evaluate whether exercise is effective in patients with AD by assessing the serum biomarkers associated with the redox status, neurotrophin levels, and inflammatory system. This nonrandomized clinical study (n = 15) involved 22 training sessions performed twice a week (60 min/session) in patients diagnosed with AD. The cognitive and self-awareness tests were performed 48 h before and after the physical training session. In patients with AD, physical training significantly improved the judgment and problem-solving domains of the memory score; however, general mental health, memory, orientation, and home/hobby domains were improved slightly, and the neurotrophin levels remained unaltered. Significantly, the markers of protein integrity also increased following exercise. Furthermore, catalase activity and ROS levels decreased, nitrite levels increased, and interleukin-4 level increased following physical training in patients with AD. Although proinflammatory cytokines remained unaltered, the levels of neuron-specific enolase, a marker of neuronal damage, decreased following exercise training in these patients. In conclusion, physical exercise training could be a safe and effective method for blocking the AD progression and improving the antioxidant capacity and anti-inflammatory system, whereas certain assessed biomarkers could be utilized to monitor AD therapy.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Catalase; DCFH; Learning and memory; Neuroinflammation; Neurotrophins; Nitrite; Oxidative stress

Mesh:

Substances:

Year:  2021        PMID: 33963521     DOI: 10.1007/s12035-021-02411-z

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  51 in total

Review 1.  Inflamm-aging. An evolutionary perspective on immunosenescence.

Authors:  C Franceschi; M Bonafè; S Valensin; F Olivieri; M De Luca; E Ottaviani; G De Benedictis
Journal:  Ann N Y Acad Sci       Date:  2000-06       Impact factor: 5.691

Review 2.  Neuroinflammation negatively affects adult hippocampal neurogenesis and cognition: can exercise compensate?

Authors:  Sinéad M Ryan; Yvonne M Nolan
Journal:  Neurosci Biobehav Rev       Date:  2015-12-13       Impact factor: 8.989

Review 3.  Oxidative imbalance in Alzheimer's disease.

Authors:  Xiongwei Zhu; Hyoung-Gon Lee; Gemma Casadesus; Jesus Avila; Kelly Drew; George Perry; Mark A Smith
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

Review 4.  How Does Exercise Reduce the Rate of Age-Associated Cognitive Decline? A Review of Potential Mechanisms.

Authors:  Greg Kennedy; Roy J Hardman; Helen Macpherson; Andrew B Scholey; Andrew Pipingas
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

5.  Evidence of increased oxidative damage in subjects with mild cognitive impairment.

Authors:  J N Keller; F A Schmitt; S W Scheff; Q Ding; Q Chen; D A Butterfield; W R Markesbery
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

Review 6.  Mitochondrial free radical generation, oxidative stress, and aging.

Authors:  E Cadenas; K J Davies
Journal:  Free Radic Biol Med       Date:  2000-08       Impact factor: 7.376

Review 7.  Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.

Authors:  Pradip K Kamat; Anuradha Kalani; Shivika Rai; Supriya Swarnkar; Santoshkumar Tota; Chandishwar Nath; Neetu Tyagi
Journal:  Mol Neurobiol       Date:  2014-12-17       Impact factor: 5.590

Review 8.  Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis.

Authors:  M Schrag; C Mueller; M Zabel; A Crofton; W M Kirsch; O Ghribi; R Squitti; G Perry
Journal:  Neurobiol Dis       Date:  2013-07-15       Impact factor: 5.996

9.  Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease.

Authors:  Manuela Padurariu; Alin Ciobica; Lucian Hritcu; Bogdan Stoica; Walther Bild; Cristinel Stefanescu
Journal:  Neurosci Lett       Date:  2009-11-13       Impact factor: 3.046

10.  Role of physical exercise in Alzheimer's disease.

Authors:  Wei-Wei Chen; Xia Zhang; Wen-Juan Huang
Journal:  Biomed Rep       Date:  2016-02-22
View more
  4 in total

Review 1.  Understanding How Physical Exercise Improves Alzheimer's Disease: Cholinergic and Monoaminergic Systems.

Authors:  Boyi Zong; Fengzhi Yu; Xiaoyou Zhang; Wenrui Zhao; Peng Sun; Shichang Li; Lin Li
Journal:  Front Aging Neurosci       Date:  2022-05-18       Impact factor: 5.702

Review 2.  Adult Hippocampal Neurogenesis in Alzheimer's Disease: An Overview of Human and Animal Studies with Implications for Therapeutic Perspectives Aimed at Memory Recovery.

Authors:  Stefano Farioli-Vecchioli; Valentina Ricci; Silvia Middei
Journal:  Neural Plast       Date:  2022-01-15       Impact factor: 3.599

Review 3.  Disentangling Mitochondria in Alzheimer's Disease.

Authors:  Ashu Johri
Journal:  Int J Mol Sci       Date:  2021-10-26       Impact factor: 5.923

4.  Effect of ivabradine on cognitive functions of rats with scopolamine-induced dementia.

Authors:  Abdel-Azim Assi; Sara Abdelnabi; Abdelraheim Attaai; Rasha B Abd-Ellatief
Journal:  Sci Rep       Date:  2022-10-10       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.